AstraZeneca Pharma India Ltd. (AZPIL) has received approval from the Central Drugs Standard Control Organisation (CDSCO) to import, sell, and distribute datopotamab deruxtecan (Dato-DXd) in India for the treatment of metastatic breast cance...
Senores Pharmaceuticals acquires Apnar Pharma in a move that strengthens its footprint across regulated global markets. The company has signed a definitive agreement to acquire a 100 percent equity stake in Apnar Pharma Private Limited, along...
Takeda’s experimental AI-crafted psoriasis pill, zasocitinib, achieved impressive results in two pivotal Phase?3 trials, marking a major milestone in the treatment of plaque psoriasis.Compared to placebo and active comparators, the once-per-day...
Alembic Pharmaceuticals Limited has received final approval from the US Food and Drug Administration (US FDA) for its Abbreviated New Drug Application (ANDA) for travoprost ophthalmic solution USP, 0.004%. The product is indicated for the reductio...
Novartis is also rapidly increasing its business footprint in India making India its biggest global R&D center outside Switzerland. The Swiss firm has a workforce exceeding 9,000 employees in Hyderabad and Mumbai. This is a significant change...
.png "Lupin Achieves Key CHMP Milestone for Ranibizumab Biosimilar")
Lupin Limited, a global pharma company, announced today that the Committee for Medicinal Products to Human Use (CHMP) of the European Medicines Agency had given a positive opinion. The opinion suggests that Lupin marketing authorization be...
Bristol Myers Squibb has launched Mosaic AI content hub, a first-of-its-kind, AI-powered platform designed to reshape how pharmaceutical content is created and delivered. Developed with Accenture, the new hub marks a major step forward in...
The summit commenced with a welcome address by Rajesh Khubchandani, Co-Founder & Managing Director, Team Marksmen Network, who emphasized, “As we start this journey, we have seen a lot of narratives and stories being told. The way a select few organi
Odisha has declared a policy on drugs and medical equipment to bring investments of 25000 crore by 2030. The policy reflects the desire of the state in turning into a large life-sciences hub in eastern India. It was unveiled during the Odisha...
Biocon Biologics Limited, an integrated global biopharmaceutical group and a subsidiary of Biocon Limited have been named under IAM (Intellectual Asset Management). IAM is a leader in international intellectual property publications, to Biocon...
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")